Barry J. Maron, MD
Potential Conflicts of Interest: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M09-2799.
Requests for Single Reprints: Barry J. Maron, MD, Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 620, Minneapolis, MN 55407; e-mail, firstname.lastname@example.org.
Maron BJ. National Electrocardiography Screening for Competitive Athletes: Feasible in the United States?. Ann Intern Med. 2010;152:324-326. doi: 10.7326/0003-4819-152-5-201003020-00012
Download citation file:
Published: Ann Intern Med. 2010;152(5):324-326.
Sudden death in young persons, associated with participation in competitive athletics, has generated considerable visibility and concern in both the general public and medical community (1–7). Such deaths, particularly when associated with unsuspected cardiovascular disease, have become a prominent public health debate focused on strategies to prevent these catastrophes (8–11). Two primary prevention initiatives have evolved in an effort to create a safer athletic environment: preparticipation screening in athlete populations to identify the culprit diseases (3, 5, 12–17), and eligibility and disqualification standards to prohibit athletes identified with cardiovascular abnormalities from engaging in competitive sports to reduce their risk (2, 4).
Learn more about subscription options.
Register Now for a free account.
Cardiology, Cardiac Diagnosis and Imaging.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only